Pliant Therapeutics Initiates Phase 2a Trial Enrollment of Bexotegrast for Primary Sclerosing Cholangitis Treatment
Pliant Therapeutics, a biopharmaceutical company focused on treating fibrosis, has begun Phase 2a enrollment for its bexotegrast to treat primary sclerosing cholangitis (PSC). The trial follows a posi ...
Acadia Pharmaceuticals’ DAYBUE™ (trofinetide) Receives FDA Approval for Rett Syndrome Treatment
Neuren Pharmaceuticals has announced that its North American partner, Acadia Pharmaceuticals, has been granted FDA approval for the use of DAYBUE™ (trofinetide) in treating Rett syndrome among pediatr ...